Director Daniel Geballe receives 80 DERs tied to LEVI Class A stock
Rhea-AI Filing Summary
Insider acquisition reported: Director Daniel W. Geballe acquired 80 dividend equivalent rights (DERs) tied to Levi Strauss & Co. Class A common stock on 08/08/2025. Each DER is a contingent right to receive one share upon settlement; the DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the related grant. The reported acquisition carried a $0.00 price and increased Mr. Geballe's direct beneficial ownership to 11,634 Class A shares. Some underlying awards may include a deferred delivery feature that applies equally to the DERs.
Positive
- Director increased direct ownership via acquisition of 80 DERs, bringing beneficial ownership to 11,634 Class A shares
Negative
- None.
Insights
TL;DR: A director received 80 DERs that vest within a year or by the next annual meeting; this is a routine, non-material compensation-related grant.
The filing documents a standard director-related equity credit in the form of dividend equivalent rights rather than an open-market purchase. The DERs are contingent rights to one share each and vest fully by the earlier of the next annual meeting or one year, indicating these are compensation or retention-linked awards. The acquisition is reported at a $0.00 price and increases direct holdings to 11,634 shares, but the absolute size (80 DERs) is small relative to total outstanding shares and appears procedural rather than signaling a substantive change in insider alignment.
TL;DR: Transaction is an administrative settlement instrument (DERs) that may convert to shares later; impact on capitalization is immaterial.
This Form 4 discloses an acquisition code (A) for 80 DERs, each representing a contingent right to one Class A share upon settlement. The report shows a post-transaction direct holding of 11,634 shares. Because the DERs convert to single shares upon settlement and vest on a defined schedule, they do not immediately change voting or cash positions until settled. Given the small quantity relative to typical public-company float, the item is unlikely to be material to valuation or control and should be viewed as routine equity compensation administration.